Baker Biotech Capital (GP), LLC Insider Trading $BCRX BIOCRYST PHARMACEUTICALS INC
Get free email notifications about insider trading for Baker Biotech Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital (GP), LLC. Baker Biotech Capital (GP), LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Baker Biotech Capital (GP), LLC in BIOCRYST PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 1,522,015 shares
Current Value: $8,629,825
Latest Transaction: Jun 01 2009
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Biotech Capital (GP), LLC in BIOCRYST PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, IDRA, INCY, NRGN, PCYC, SGEN, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 3.89 | 19,585 | 76,088 | 1,522,015 | 1.5 M to 1.5 M (-1.27 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 3.86 | 50,574 | 195,423 | 1,541,600 | 1.6 M to 1.5 M (-3.18 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 4.12 | 48,438 | 199,700 | 1,592,174 | 1.6 M to 1.6 M (-2.95 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 4.30 | 9,409 | 40,471 | 1,640,612 | 1.7 M to 1.6 M (-0.57 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 4.50 | 69,762 | 314,215 | 1,650,021 | 1.7 M to 1.7 M (-4.06 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 4.45 | 38,710 | 172,395 | 1,719,783 | 1.8 M to 1.7 M (-2.20 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 0.98 | 2,339 | 2,287 | 1,758,493 | 1.8 M to 1.8 M (+0.13 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 0.91 | 9,831 | 8,987 | 1,756,154 | 1.7 M to 1.8 M (+0.56 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 1.00 | 96,033 | 96,033 | 1,746,323 | 1.7 M to 1.7 M (+5.82 %) |
Page: 1